Eli Lilly and Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (46)

Latest Posts

About This Stock More About This Stock
Trump Announces Plan To Reign In Drug Prices And Pharma Stocks Rally
Article By: Zacks Investment Research
Sunday, May 13, 2018 11:37 AM EDT
President Trump unveiled his plan to control US drug prices. Stock prices of the biggest drug companies briefly declined, only to reverse course and ended the day broadly higher. The reason? The plan doesn’t seem to be “taking them on” at all.
In this article: LLY, MRK, AMGN, EXEL, ABBV
Read
Week In Review: $3.4 Billion Week For China Life Science Deals
Article By: ChinaBio® Today
Saturday, May 12, 2018 4:50 PM EDT
Armo Biosciences, a Bay Area immuno-oncology company, agreed to be acquired by Eli Lilly. Lilly offered to pay $50 per share for Armo, a three-fold increase from the IPO price and a 67% jump from its previous close.
In this article: AZN, LLY, ARMO, GILD
Read
Eli Lilly Tops Q1 Earnings & Sales, Ups 2018 View
Article By: Zacks Investment Research
Tuesday, April 24, 2018 9:48 AM EDT
Lilly beat on first quarter earnings. The company reported EPS of $1.34 per share.
In this article: LLY
Read
5 Drug Stocks Poised To Surpass On Earnings This Quarter
Article By: Zacks Investment Research
Tuesday, April 17, 2018 3:13 PM EDT
The first-quarter earnings season has just kicked off.
In this article: LLY, PFE, ABBV, PETX, CTLT
Read
Week In Review: Concord Medical Raises $240 Million For China Radiology Services
Article By: ChinaBio® Today
Saturday, April 7, 2018 4:30 PM EDT
Concord Medical Services announced that CICC Capital led an investment of between $238 million and $286 million in Concord’s subsidiary Beijing Meizhong Jiahe Hospital Management. The investors will hold 37.5% to 41.9% of Meizhong Jiahe's equity.
In this article: CCM, LLY
Read

PARTNER HEADLINES

Latest Tweets for $LLY

No tweets yet!